Quantcast

Europe

Moderna Announces Amendment to Current Supply Agreement with United Kingdom Government for an Additional 2 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)

UK government has now secured 7 million doses of mRNA-1273 Agreement reflects Moderna’s commitment to make its vaccine available in

Posted in Europe, news | Tagged , , | Leave a comment

F4 Pharma: treatment for the most severely affected patients clinical trial with FX06 starts in France

F4 Pharma, a clinical-stage biopharmaceutical company developing FX06, an anti-inflammatory therapeutic that has shown to improve vascular integrity, has included the first patient with severe COVID-19 in a study named “FX-COVID”, to confirm the efficacy and safety of FX06 in hospitalized patients receiving mechanical ventilation.

Posted in Europe, news | Tagged , | Leave a comment

Pfizer’s, Biontech’s Covid-19 vaccine candidate meets endpints in P3 trial

Pfizer’s and Biontech’s vaccine candidate for COVID-19 has met all the study’s primary efficacy endpoints.

Posted in Europe, news, North America | Tagged , , , , | Leave a comment

AstraZeneca’s olaparib + bevacizumab cleared as certain cancer treatment in EU

AstraZeneca and MSD’s Lynparza (olaparib) has been approved in the European Union (EU) for the 1st-line maintenance treatment with bevacizumab of patients with homologous recombination deficient (HRD)-positive advanced ovarian cancer.

Posted in Europe, news | Tagged , , , , | Leave a comment

Novartis data show early treatment with Mayzent® (siponimod) delays disability progression and show benefits in cognitive performance in patients with secondary progressive multiple sclerosis (SPMS)

Post hoc EXPAND analysis showed improvements in cognitive processing speed in patients with active and non-active SPMS treated with Mayzent1 

Posted in Europe, news | Tagged , | Leave a comment

Gyroscope Therapeutics Announces Initiation of Phase II Programme Evaluating its Investigational Gene Therapy, GT005, for Dry Age-Related Macular Degeneration

Gyroscope doses first patient in Phase II EXPLORE trial evaluating GT005 in people with geographic atrophy secondary to dry AMD with a mutation in the Complement Factor I gene.

Posted in Europe, news | Leave a comment

VarmX Raises €32 Million in Series B Financing to Develop Innovative Reversal Agent for the Treatment and Prevention of Severe Bleeding in Patients on Oral Anticoagulants

VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces the completion of a €32 million Series B financing round.

Posted in Europe, news | Tagged | Leave a comment

NTG Nordic Transport Group increases the share capital to acquire remaining 15% of the shares in Ebrex Business Solutions Ltd.

NTG Nordic Transport Group increases the share capital to acquire remaining 15% of the shares in Ebrex Business Solutions Ltd.

Posted in Europe, news | Leave a comment

GENFIT: Enhances Board of Directors with Two Strategic Appointments

Lille (France), Cambridge (Massachusetts, United States), July 7, 2020 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated

Posted in Europe, news | Tagged | Leave a comment

Myovant Sciences Presents Additional Data on Relugolix Combination Therapy from Phase 3 LIBERTY Studies in Women with Uterine Fibroids and from Ovulation Inhibition Study

Data from Phase 3 LIBERTY program show improvement in patient-reported outcomes in addition to improvement in hemoglobin levels in anemic

Posted in Europe, news | Tagged | Leave a comment